ACE2 and COVID-19: Severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) was the designation given to the illness after it was later determined to be caused by a new coronavirus.[1] Even though most COVID-19 patients suffer from pulmonary symptoms, approximately 5% of individuals suffer from multi-organ dysfunction, which increases of morbidity and mortality from the disease.[2] SARS-CoV-2 is an enveloped virus that can access the cell via angiotensin-converting enzyme 2 (ACE2), the main receptor for this virus.